cbdMD (YCBD) Gross Margin (2016 - 2025)

cbdMD (YCBD) reported Gross Margin of 59.82% for Q4 2025, down 668.0% on a YoY basis from 10.53% in Q4 2024, and up 1.69% sequentially from 58.83% in Q3 2025.

cbdMD (YCBD) Gross Margin (2016 - 2025) Analysis & Trends

cbdMD (YCBD) has 10 years of Gross Margin data on file, last reported at 59.82% in Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 668.0% year-over-year to 59.82%; the trailing twelve-month figure through Dec 2025 stood at 60.59% (up 37.0% YoY), and the FY2025 full-year result was 62.37%, up 215.0% from the prior year.
  • Gross Margin improved to 59.82% in Q4 2025, from 58.83% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 72.91% in Q3 2023 to a low of 49.11% in Q3 2024.
  • A 5-year average of 61.44% and a median of 62.58% in 2023 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin surged 2104 bps in 2023 and tumbled 2380 bps in 2024, its largest moves.
  • Tracing YCBD's Gross Margin over 5 years: stood at 50.66% in 2021, then increased by 13 bps to 57.17% in 2022, then climbed by 16 bps to 66.18% in 2023, then climbed by 0 bps to 66.5% in 2024, then retreated by 10 bps to 59.82% in 2025.
  • Business Quant data shows YCBD's Gross Margin at 59.82% in Q4 2025, 58.83% in Q3 2025, and 61.45% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn 59.82%

Historic Data

Download Data
DateValue
Dec 31, 2025 59.82%
Sep 30, 2025 58.83%
Jun 30, 2025 61.45%
Mar 31, 2025 62.31%
Dec 31, 2024 66.50%
Sep 30, 2024 49.11%
Jun 30, 2024 65.78%
Mar 31, 2024 58.97%
Dec 31, 2023 66.18%
Sep 30, 2023 72.91%
Jun 30, 2023 62.84%
Mar 31, 2023 64.35%
Dec 31, 2022 57.17%
Sep 30, 2022 51.88%
Jun 30, 2022 69.04%
Mar 31, 2022 66.91%
Dec 31, 2021 50.66%
Sep 30, 2021 55.27%
Jun 30, 2021 63.33%
Mar 31, 2021 65.47%